Michael Overdorf
Corporate Officer/Principal chez ANNEXON, INC.
Fortune : 614 046 $ au 31/03/2024
Profil
Michael Overdorf is currently the Chief Business Officer & Executive Vice President at Annexon, Inc. Prior to his current position, he worked at Eli Lilly & Co. as the COO-Bio-Medicines Business Unit from 2001 to 2020.
He completed his undergraduate degree at Wabash College in 1992 and obtained an MBA from Harvard Business School in 1999.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANNEXON, INC.
0,10% | 20/02/2024 | 85 641 ( 0,10% ) | 614 046 $ | 31/03/2024 |
Postes actifs de Michael Overdorf
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXON, INC. | Corporate Officer/Principal | 30/07/2020 |
Anciens postes connus de Michael Overdorf
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/07/2020 |
Formation de Michael Overdorf
| Wabash College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ANNEXON, INC. | Health Technology |
